• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Hmmm..one drug causes bladder cancer, another pancreatic cancer









Keep snickering. I'll be laughing at the bank with my bonus checks this summer from Nesina launch. You must be one those TAP pussies that can't hack it in diabetes.

Oh yeah, I forgot. You are one of those famous Takeda "Diabetes Specialists" that we've heard so much about. I expect you to use your mad skills to drive Nesina to the top of the Rx charts......and when you fail (without Lilly support) who will you blame?